Cancer research
AI-Powered Prostate Cancer Diagnosis: Oxford University Study
Researchers at the University of Oxford, led by Professor Clare Verrill, are investigating the potential of artificial intelligence (AI) to improve prostate cancer diagnosis and treatment decisions. The Vanguard Path study, funded by £1.9 million from Prostate Cancer UK, will test the ArteraAI Prostate Biopsy Assay technology on prostate